流通市值:21.91亿 | 总市值:21.91亿 | ||
流通股本:1.77亿 | 总股本:1.77亿 |
报告期 | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 |
公司类型 | 通用 | 通用 | 通用 | 通用 |
流动资产: | ||||
货币资金 | 19,011,948.01 | 7,403,249.62 | 17,213,845.22 | 17,593,242.63 |
应收票据及应收账款 | 9,439,520.74 | 3,513,922.03 | 5,069,850.97 | 4,248,409.74 |
应收账款 | 9,439,520.74 | 3,513,922.03 | 5,069,850.97 | 4,248,409.74 |
预付款项 | 2,903,426.71 | 6,927,858.45 | 1,872,402.07 | 1,508,022.97 |
其他应收款合计 | 32,110,261.19 | 30,931,913.93 | 31,903,231.05 | 31,261,620.73 |
存货 | 182,677,720.37 | 183,751,881.9 | 168,014,718.32 | 175,883,233.62 |
其他流动资产 | 876,694.02 | 808,503.5 | 346,781.76 | 1,045,344.31 |
流动资产平衡项目 | 0 | 0 | 0 | 0 |
流动资产合计 | 247,019,571.04 | 233,337,329.43 | 224,420,829.39 | 231,539,874 |
非流动资产: | ||||
其他权益工具投资 | 1,000,000 | 1,000,000 | 1,000,000 | 1,000,000 |
固定资产 | 83,666,626.68 | 85,426,227.99 | 86,855,466.07 | 88,268,165.95 |
生产性生物资产 | 8,485,869.1 | 9,181,592.17 | 9,877,315.24 | 10,573,038.31 |
使用权资产 | 876,694.02 | 876,694.02 | 978,027.81 | 978,027.81 |
无形资产 | 143,135,581.32 | 144,984,209.68 | 146,736,703.47 | 148,604,334.57 |
长期待摊费用 | 1,481,551.55 | 1,584,643.65 | 1,452,577.43 | 1,339,545.74 |
递延所得税资产 | 505,080.77 | 505,080.77 | 504,425.87 | 505,078.37 |
其他非流动资产 | - | 0 | - | 136,380 |
非流动资产平衡项目 | 0 | 0 | 0 | 0 |
非流动资产合计 | 239,151,403.44 | 243,558,448.28 | 247,404,515.89 | 251,404,570.75 |
资产平衡项目 | 0 | 0 | 0 | 0 |
资产总计 | 486,170,974.48 | 476,895,777.71 | 471,825,345.28 | 482,944,444.75 |
流动负债: | ||||
短期借款 | 5,000,000 | - | - | - |
应付票据及应付账款 | 81,371,650.87 | 87,569,140.43 | 76,491,705.4 | 82,511,111.88 |
应付账款 | 81,371,650.87 | 87,569,140.43 | 76,491,705.4 | 82,511,111.88 |
预收款项 | 737,170.85 | 1,135,440.55 | 1,009,915.52 | 271,799.7 |
合同负债 | 2,806,372.68 | 3,497,238.76 | 2,335,700.44 | 2,243,408.02 |
应付职工薪酬 | 13,151,978.45 | 16,044,784.33 | 14,531,777.76 | 15,067,035.71 |
应交税费 | 68,315,520.5 | 60,432,646.2 | 61,785,732.31 | 63,234,522.02 |
其他应付款合计 | 117,227,724.33 | 114,420,879.18 | 117,198,356.13 | 122,710,581.92 |
其中:应付利息 | 4,517,182.72 | 4,438,239.15 | 4,376,125.88 | 4,298,029.42 |
一年内到期的非流动负债 | 684,212.81 | 684,212.81 | 772,361.2 | 772,361.2 |
其他流动负债 | 248,896.48 | 331,152.84 | 275,537.08 | 197,143.53 |
流动负债平衡项目 | 0 | 0 | 0 | 0 |
流动负债合计 | 289,543,526.97 | 284,115,495.1 | 274,401,085.84 | 287,007,963.98 |
非流动负债: | ||||
长期借款 | 50,000,000 | 50,000,000 | 50,000,000 | 50,000,000 |
预计负债 | - | 23,042,276.04 | 23,042,276.04 | 23,042,276.04 |
递延所得税负债 | 223,580.92 | 223,580.92 | 224,240.19 | 224,240.19 |
非流动负债平衡项目 | 0 | 0 | 0 | 0 |
非流动负债合计 | 50,223,580.92 | 73,265,856.96 | 73,266,516.23 | 73,266,516.23 |
负债平衡项目 | 0 | 0 | 0 | 0 |
负债合计 | 339,767,107.89 | 357,381,352.06 | 347,667,602.07 | 360,274,480.21 |
所有者权益(或股东权益): | ||||
实收资本(或股本) | 177,408,000 | 177,408,000 | 177,408,000 | 177,408,000 |
资本公积 | 557,054,994.39 | 556,573,662.27 | 556,320,705.15 | 555,610,998.03 |
盈余公积 | 5,861,319.98 | 5,861,319.98 | 5,861,319.98 | 5,861,319.98 |
未分配利润 | -594,967,575.03 | -621,565,902.48 | -616,722,523.02 | -617,593,218.51 |
归属于母公司股东权益平衡项目 | 0 | 0 | 0 | 0 |
归属于母公司股东权益合计 | 145,356,739.34 | 118,277,079.77 | 122,867,502.11 | 121,287,099.5 |
少数股东权益 | 1,047,127.25 | 1,237,345.88 | 1,290,241.1 | 1,382,865.04 |
股东权益平衡项目 | 0 | 0 | 0 | 0 |
股东权益合计 | 146,403,866.59 | 119,514,425.65 | 124,157,743.21 | 122,669,964.54 |
负债和股东权益合计 | 486,170,974.48 | 476,895,777.71 | 471,825,345.28 | 482,944,444.75 |
公告日期 | 2024-10-29 | 2024-08-31 | 2024-04-30 | 2024-04-30 |
审计意见(境内) | 标准无保留意见 |